New anti-VEGF therapies seeking Aussie approval
The suppliers of two new anti-VEGF therapies recently cleared in the US that work to reduce macular disease treatment burdens ...
The suppliers of two new anti-VEGF therapies recently cleared in the US that work to reduce macular disease treatment burdens ...
The Australian College of Optometry (ACO) is joining Optometry Australia (OA)’s call for a $1 million investment into a collaborative ...
Key ophthalmic organisations have revealed their federal election wish lists, drawing attention to issues such as workforce maldistribution and access ...
A new study has shown up to a third of neovascular age-related macular degeneration (nAMD) patients may safely be ...
Oral therapeutics, intravitreal injections and telehealth MBS items are among six areas Optometry Australia is calling for change so the ...
The Macular Disease Foundation Australia (MDFA)’s first-ever social impact survey has revealed a quarter of patients have low levels of ...
Prominent Australian Ms Ita Buttrose has used a National Press Club address to reveal alarming new data showing that 47,000 ...
The MBS Taskforce has published its final report into ophthalmology items containing recommendations that have come under intense scrutiny from ...
The head of ophthalmic surgery at a major public hospital says the current Medicare fee for intravitreal injections only creates ...
A taskforce overseeing a review into optometric Medicare items has backed 11 of 14 recommendations by an optometry committee. However, ...
Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited